Continuing Education for Neurology | CME Neurology Course Credits

Page 4 of 5

Results 91 - 120 of 122

SMA Updates from Around the World

9920-0004-conf_covg_icon_263x149

Updates in SMA from Charlotte, North Carolina

Updates in SMA from Austin, Texas

Technology Improving SMA Patients’ Quality of Life

Nusinersen Treatment Outcomes in Later-Onset SMA

Patients with Severe SMA Need Additional Respiratory Management

Clear Expectations Needed in SMA Patient Management

Improvements in Quality of Life for Patients with Neuromuscular Diseases

Updates in SMA and Gene Therapy from Copenhagen, Denmark

The Changing Landscape of SMA–Updates from Copenhagen, Denmark

Are You Ready for Gene Replacement Therapy?

The Changing Landscape of SMA–Updates from Anaheim, CA

Urgency for Early Diagnosis and Treatment of SMA

sma-journal-icon_263x0

Gene Therapy for SMA: An Emerging Treatment Option for a Devastating Disease

SMA: Data, Insights and Practice

From Bench to Bedside: Gene Therapy Approaches for Rare Diseases

What’s New in Spinal Muscular Atrophy? Reporting from Dallas

SMA Updates from Los Angeles

Updates in SMA and Gene Therapy from Arlington, VA

Targeting B-cells in Primary Progressive MS (PPMS)

Comorbidities and Selection of DMTs

The Gut Microbiota in MS

Early MS: Induction Therapy and Escalation Strategies

Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS

Individualizing Patient Education in Treatment Choice: Practical Strategies

A 30 y/o Female w/2-year History of Shoulder Weakness and Elevated AST and ALT

32 y/o Male w/Progressive Weakness, Dilated Cardiomyopathy & Respiratory...

A 60 y/o Male w/4-year History Of Shoulder Weakness

Individualizing Patient Education in Treatment Choice: Practical Strategies

Addressing Common Barriers to Adherence

Page 4 of 5

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

10 Vista Drive, Old Lyme, CT USA